Sildenafil

The discovery and development of Viagra®(sildenafil citrate).- Sildenafil, pharmacology of a highly selective PDE5 inhibitor.- Sildenafil citrate: a 5-year update on the worldwide treatment of 20 million men with erectile dysfunction.- Current and future strategies for preventing and managing erectile dysfunction following radical prostatectomy.- Neurologic erectile dysfunction.- Therapy of erectile dysfunction (ED) with sildenafil improves quality of life (QoL) and partnership (QoP).- Erectile dysfunction, depression, and pharmacological treatments: biologic interactions.- Potential role for the PDE5 inhibitor sildenafil in the treatment of female sexual dysfunction.- Molecular processing of sildenafil in endothelial function: potential applications in cardiovascular diseases.- Sildenafil and cardiovascular events — drug interactions.- Cardiovascular safety of sildenafil in the treatment of erectile dysfunction.- NO pathway and phosphodiesterase inhibitors in pulmonary arterial hypertension.- The phosphodiesterase V inhibitor low responder study (PILRS) in patients with erectile dysfunction — A rationale for a PDE5 inhibitor combination therapy.- Extended clinical use of sildenafil in patients with IPP, prostatitis and infertility syndrome.- The cultural impact of sildenafil.